200 related articles for article (PubMed ID: 9596107)
1. Polymorphism of the beta2-adrenoceptor and the response to long-term beta2-agonist therapy in asthma.
Hancox RJ; Sears MR; Taylor DR
Eur Respir J; 1998 Mar; 11(3):589-93. PubMed ID: 9596107
[TBL] [Abstract][Full Text] [Related]
2. Limited beta2-adrenoceptor haplotypes display different agonist mediated airway responses in asthmatics.
van Veen A; Wierenga EA; Westland R; Weller FR; Hart GA; Jansen HM; Jonkers RE
Respir Res; 2006 Jan; 7(1):19. PubMed ID: 16448568
[TBL] [Abstract][Full Text] [Related]
3. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM
J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
[TBL] [Abstract][Full Text] [Related]
4. Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics.
Lima JJ; Thomason DB; Mohamed MH; Eberle LV; Self TH; Johnson JA
Clin Pharmacol Ther; 1999 May; 65(5):519-25. PubMed ID: 10340917
[TBL] [Abstract][Full Text] [Related]
5. Tachyphylaxis to beta2-agonists in Spanish asthmatic patients could be modulated by beta2-adrenoceptor gene polymorphisms.
Tellería JJ; Blanco-Quirós A; Muntión S; Antonio Garrote J; Arranz E; Armentia A; Díez I; Castro J
Respir Med; 2006 Jun; 100(6):1072-8. PubMed ID: 16263254
[TBL] [Abstract][Full Text] [Related]
6. Bronchodilator response in relation to beta2-adrenoceptor haplotype in patients with asthma.
Taylor DR; Epton MJ; Kennedy MA; Smith AD; Iles S; Miller AL; Littlejohn MD; Cowan JO; Hewitt T; Swanney MP; Brassett KP; Herbison GP
Am J Respir Crit Care Med; 2005 Sep; 172(6):700-3. PubMed ID: 15976384
[TBL] [Abstract][Full Text] [Related]
7. The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma.
Israel E; Drazen JM; Liggett SB; Boushey HA; Cherniack RM; Chinchilli VM; Cooper DM; Fahy JV; Fish JE; Ford JG; Kraft M; Kunselman S; Lazarus SC; Lemanske RF; Martin RJ; McLean DE; Peters SP; Silverman EK; Sorkness CA; Szefler SJ; Weiss ST; Yandava CN
Am J Respir Crit Care Med; 2000 Jul; 162(1):75-80. PubMed ID: 10903223
[TBL] [Abstract][Full Text] [Related]
8. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.
Peters S
Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066
[TBL] [Abstract][Full Text] [Related]
9. Beta2-adrenergic receptor polymorphisms affect response to treatment in children with severe asthma exacerbations.
Carroll CL; Stoltz P; Schramm CM; Zucker AR
Chest; 2009 May; 135(5):1186-1192. PubMed ID: 19029431
[TBL] [Abstract][Full Text] [Related]
10. Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing.
Martinez FD; Graves PE; Baldini M; Solomon S; Erickson R
J Clin Invest; 1997 Dec; 100(12):3184-8. PubMed ID: 9399966
[TBL] [Abstract][Full Text] [Related]
11. Influence of beta2-adrenoceptor polymorphisms on the response to chronic use of albuterol in asthmatic children.
Giubergia V; Gravina LP; Castaños C; Chertkoff L; Grenoville M
Pediatr Pulmonol; 2008 May; 43(5):421-5. PubMed ID: 18383333
[TBL] [Abstract][Full Text] [Related]
12. Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate.
Bleecker ER; Nelson HS; Kraft M; Corren J; Meyers DA; Yancey SW; Anderson WH; Emmett AH; Ortega HG
Am J Respir Crit Care Med; 2010 Apr; 181(7):676-87. PubMed ID: 19910613
[TBL] [Abstract][Full Text] [Related]
13. [Polymorphism of beta 2-adrenergic receptors].
Weglarz L; Grzanka A; Kierot J; Wilczok T
Wiad Lek; 2003; 56(5-6):283-8. PubMed ID: 14526489
[TBL] [Abstract][Full Text] [Related]
14. The effect of polymorphism of the beta-2 adrenergic receptor on the response to beta-2 agonist in bronchial asthma patients.
Syamsu ; Yusuf I; Budu ; Patellongi I
Acta Med Indones; 2007; 39(1):8-12. PubMed ID: 17297203
[TBL] [Abstract][Full Text] [Related]
15. Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthma.
Israel E; Drazen JM; Liggett SB; Boushey HA; Cherniack RM; Chinchilli VM; Cooper DM; Fahy JV; Fish JE; Ford JG; Kraft M; Kunselman S; Lazarus SC; Lemanske RF; Martin RJ; McLean DE; Peters SP; Silverman EK; Sorkness CA; Szefler SJ; Weiss ST; Yandava CN;
Int Arch Allergy Immunol; 2001; 124(1-3):183-6. PubMed ID: 11306963
[TBL] [Abstract][Full Text] [Related]
16. Beta2-adrenoceptor polymorphisms predict response to beta2-agonists in children with acute asthma.
Martin AC; Zhang G; Rueter K; Khoo SK; Bizzintino J; Hayden CM; Geelhoed GC; Goldblatt J; Laing IA; Le Souëf PN
J Asthma; 2008 Jun; 45(5):383-8. PubMed ID: 18569231
[TBL] [Abstract][Full Text] [Related]
17. Beta-adrenoceptor responses of the airways: for better or worse?
Broadley KJ
Eur J Pharmacol; 2006 Mar; 533(1-3):15-27. PubMed ID: 16469310
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetic tests in asthma therapy.
Yu IW; Bukaveckas BL
Clin Lab Med; 2008 Dec; 28(4):645-65. PubMed ID: 19059068
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
[TBL] [Abstract][Full Text] [Related]
20. The influence of the AA 16 beta 2-adrenoceptor polymorphism on systemic and airway responses in asthma.
van Veen A; Weller FR; Wierenga EA; Jansen HM; Jonkers RE
Pulm Pharmacol Ther; 2008; 21(1):73-8. PubMed ID: 17292646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]